Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Livestock-associated meticillin-resistant Staphylococcus aureus (LA-MRSA) among MRSA from humans across the EU/EEA, 2013: ECDC survey
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a ‘One Health’ issue. The ECDC advocates for periodic systematic surveys or integrated multi-sectorial surveillance to facilitate control measures.
Imported methicillin-resistant Staphylococcus aureus, SwedenArchived
The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East.
Panton-Valentine leukocidin-positive Staphylococcus aureus infections in returning travelersArchived
The authors present data on 15 individuals infected by Panton-Valentine leukocidin (PVL) -producing strains of Staphylococcus aureus. Intra-familial spread was documented in one case, and occupational transmission was most likely in another case. spa typing of the strains revealed a broad range of variants, though some strains were clonally related. Methicillin-resistant Staphylococcus aureus (MRSA) was found in three cases.
Country-to-country transfer of patients and the risk of multi-resistant bacterial infectionArchived
This review outlines how increasing modalities of travel, such as aeromedical evacuation of civilians and of military personnel, medical tourism and any shared healthcare across countries, are risks for the transmission of multidrug-resistant organisms via the patient, from country to country.